157 related articles for article (PubMed ID: 12603693)
21. The evolution of T-cell depletion in haploidentical stem-cell transplantation.
Or-Geva N; Reisner Y
Br J Haematol; 2016 Mar; 172(5):667-84. PubMed ID: 26684279
[TBL] [Abstract][Full Text] [Related]
22. Immunological aspects of haploidentical stem cell transplantation in children.
Handgretinger R; Lang P; Schumm M; Pfeiffer M; Gottschling S; Demirdelen B; Bader P; Kuci S; Klingebiel T; Niethammer D
Ann N Y Acad Sci; 2001 Jun; 938():340-57; discussion 357-8. PubMed ID: 11458522
[TBL] [Abstract][Full Text] [Related]
23. Megadose stem cell administration as a route to mixed chimerism.
Or-Geva N; Reisner Y
Curr Opin Organ Transplant; 2014 Aug; 19(4):334-41. PubMed ID: 24905022
[TBL] [Abstract][Full Text] [Related]
24. Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia.
Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schauenstein K; Schumm M; Handgretinger R
Bone Marrow Transplant; 2000 Mar; 25(5):513-7. PubMed ID: 10713628
[TBL] [Abstract][Full Text] [Related]
25. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.
Martino R; Martín-Henao G; Sureda A; Altés A; Canals C; Brunet S; Sierra J
Haematologica; 2000 Nov; 85(11):1165-71. PubMed ID: 11064469
[TBL] [Abstract][Full Text] [Related]
27. Haploidentical transplantation: repurposing cyclophosphamide.
Jones RJ
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1771-2. PubMed ID: 23022466
[No Abstract] [Full Text] [Related]
28. Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases.
Gaipa G; Dassi M; Perseghin P; Venturi N; Corti P; Bonanomi S; Balduzzi A; Longoni D; Uderzo C; Biondi A; Masera G; Parini R; Bertagnolio B; Uziel G; Peters C; Rovelli A
Bone Marrow Transplant; 2003 May; 31(10):857-60. PubMed ID: 12748661
[TBL] [Abstract][Full Text] [Related]
29. Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation.
Haen SP; Groh C; Schumm M; Backert L; Löffler MW; Federmann B; Faul C; Dörfel D; Vogel W; Handgretinger R; Kanz L; Bethge WA
Ann Hematol; 2017 May; 96(5):817-827. PubMed ID: 28247058
[TBL] [Abstract][Full Text] [Related]
30. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation.
Ball LM; Lankester AC; Bredius RG; Fibbe WE; van Tol MJ; Egeler RM
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S35-8. PubMed ID: 15812528
[TBL] [Abstract][Full Text] [Related]
31. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
[TBL] [Abstract][Full Text] [Related]
32. Immune reconstitution after haploidentical hematopoietic stem cell transplantation.
Chang YJ; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2014 Apr; 20(4):440-9. PubMed ID: 24315844
[TBL] [Abstract][Full Text] [Related]
33. Generation and flow cytometric quality control of clinical-scale TCRαβ/CD19-depleted grafts.
Bremm M; Cappel C; Erben S; Jarisch A; Schumm M; Arendt A; Bonig H; Klingebiel T; Koehl U; Bader P; Huenecke S
Cytometry B Clin Cytom; 2017 Mar; 92(2):126-135. PubMed ID: 26416332
[TBL] [Abstract][Full Text] [Related]
34. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
Lang P; Schumm M; Greil J; Bader P; Klingebiel T; Müller I; Feuchtinger T; Pfeiffer M; Schlegel PG; Niethammer D; Handgretinger R
Klin Padiatr; 2005; 217(6):334-8. PubMed ID: 16307419
[TBL] [Abstract][Full Text] [Related]
35. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
Sestili S; Labopin M; Ruggeri A; Velardi A; Ciceri F; Maertens J; Kanz L; Aversa F; Lewalle P; Bunjes D; Mohty M; Nagler A
Cancer; 2018 May; 124(10):2142-2150. PubMed ID: 29469924
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic stem-cell transplantation from haploidentical donors using 'ex-vivo' T-cell depletion in pediatric patients with hematological malignancies: state of the art review.
González-Vicent M; Díaz Perez MA
Curr Opin Oncol; 2018 Nov; 30(6):396-401. PubMed ID: 30307414
[TBL] [Abstract][Full Text] [Related]
37. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
38. Graft engineering for allogeneic haploidentical stem cell transplantation.
Tabilio A; Falzetti F; Zei T; De Ioanni M; Bonifacio E; Battelli F; Iacucci Ostini R; Ballanti S; Cimminiello M; Capponi M; Silvani C; Minelli O; Fettucciari K; Marconi P; Rosati E; Santucci A; Di Ianni M; Aversa F; Martelli MF
Blood Cells Mol Dis; 2004; 33(3):274-80. PubMed ID: 15528144
[TBL] [Abstract][Full Text] [Related]
39. Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation.
Bastien JP; Roy J; Roy DC
Semin Oncol; 2012 Dec; 39(6):674-82. PubMed ID: 23206844
[TBL] [Abstract][Full Text] [Related]
40. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.
Kałwak K; Porwolik J; Mielcarek M; Gorczyńska E; Owoc-Lempach J; Ussowicz M; Dyla A; Musiał J; Paździor D; Turkiewicz D; Chybicka A
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1388-401. PubMed ID: 20382248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
